Document:

Form of Restricted Stock Agreement

 Exhibit 10.3 
 BLUE COAT SYSTEMS, INC. 
 2007
NEW EMPLOYEE STOCK INCENTIVE PLAN: 
 NOTICE
OF RESTRICTED STOCK AWARD 
 You have been granted restricted shares of
Common Stock (the “Shares”) of Blue Coat Systems, Inc. (the “Company”), in consideration for your services with the Company, on the following terms: 
  

			
	Name of Recipient:	  	«Name»
		
	Total Number of Shares Granted:	  	«TotalShares»
		
	Board Approval Date:	  	[Date]
		
	Fair Market Value per Share on Grant Date:	  	$[Value Per Share]
		
	Total Fair Market Value of Award on Grant Date:	  	$[Total Value]
		
	Vesting Commencement Date:	  	«VestDay»
		
	Quarterly Vesting Dates:	  	March 15th; June 15th; September 15th;
December 15th
		
	Vesting Schedule:	  	     [specify number] Shares will vest on              (the “Initial Vesting Date”),
subject to your completion of continuous service as an employee or consultant of the Company or a subsidiary of the Company (“Service”) from the Vesting Commencement Date through the Initial Vesting Date. Thereafter, an additional 6.25% of
the Shares will vest on each of the next 12 Quarterly Vesting Dates, subject to your completion of continuous Service during the period between Quarterly Vesting Dates.      Shares will vest on
             (“Final Vesting Date”), subject to your completion of continuous Service during the period between the last Quarterly Vesting Date and the Final Vesting
Date.

 You and the Company agree that these Shares are awarded under and governed by the terms and conditions of the
Restricted Stock Agreement, which is attached to and made a part of this document, and the Company’s 2007 New Employee Stock Incentive Plan (the “Plan”). 

 You further agree that the Company may deliver by email all documents relating to the Plan or this award (including,
without limitation, prospectuses required by the Securities and Exchange Commission) and all other documents that the Company is required to deliver to its security holders (including, without limitation, annual reports and proxy statements). You
also agree that the Company may deliver these documents by posting them on a web site maintained by the Company or by a third party under contract with the Company. If the Company posts these documents on a web site, it will notify you by email. By
your signature below, you agree to pay any withholding taxes due on award, vesting or transfer of the Shares. 
  

							
	RECIPIENT:	 		 	BLUE COAT SYSTEMS, INC.
				
	  
	 		 	By:	  	  

	  
	 		 	Title:	  	  

  

 2 

 BLUE COAT SYSTEMS, INC. 
 2007 NEW EMPLOYEE STOCK INCENTIVE PLAN: 
 RESTRICTED STOCK AGREEMENT 
  

			
	Grant	  	On the terms and conditions set forth in the Notice of Restricted Stock Award and this Agreement, the Company hereby grants to you the number of Shares set forth in the Notice of Restricted
Stock Award.
		
	Payment for Shares	  	No payment is required for the Shares that you are receiving, except for satisfying any withholding taxes that may be due as a result of the grant of this award, the vesting of the Shares or the
transfer of the Shares.
		
	Vesting	  	The Shares will vest and become non-forfeitable in installments, as shown in the Notice of Restricted Stock Award. No additional Shares vest after your Service has terminated for any
reason.
		
	Change in
Control	  	 The terms set forth in the Plan will control the extent to which the vesting of Shares accelerates on a Change in Control or Involuntary Termination;
provided, however, that the Notice of Award may modify the acceleration of the vesting of Shares on a Change in Control.
  
 Change in Control and Involuntary Termination are defined in the Plan.

		
	Forfeiture	  	If your Service terminates for any reason, then this award will automatically terminate (and the Shares shall be forfeited) with respect to any Shares that (a) have not vested before your
termination date and (b) do not vest as a result of the termination. You will receive no payment for any Shares that are forfeited under this Agreement. The Company determines when your Service terminates for this purpose.
		
	 Leaves of Absence and
 Part-Time
Work
	  	 For purposes of this award, your Service does not terminate when you go on a military leave, a sick leave or another bona fide leave of
absence, if the leave was approved by the Company in writing and if continued crediting of Service is required by applicable law, the Company’s leave of absence policy or the terms of your leave. But your Service terminates when the approved
leave ends, unless you immediately return to active work.
  
 If you go on a leave of
absence, then the vesting schedule specified in the Notice of Restricted Stock Award may be adjusted in accordance with the Company’s leave of absence policy or the terms of your leave.

  

 3 

			
	 Stock
 Certificates
	  	The certificates for Shares that have not vested may be held in escrow by the Company.
		
	Voting Rights	  	You may vote your Shares even before they vest until or unless such Shares are forfeited.
		
	Withholding Taxes	  	No stock certificates will be released to you unless you have made arrangements, acceptable to the Company, to pay any and all withholding taxes that may be due as a result of (a) the grant of
this award, (b) the vesting of the Shares or (c) the transfer of the Shares to you. With the Company’s consent, these arrangements may include (i) withholding Shares of Company stock granted hereunder with a fair market value equal to or
less than the minimum amount of taxes the Company is required to withhold, (ii) surrendering shares that you previously acquired or (iii) the payment of withholding taxes from the proceeds of the sale of shares through a Company-approved
broker. The fair market value of the shares you surrender, determined as of the date taxes otherwise would have been withheld in cash, will be applied as a credit against the withholding taxes. The Company reserves the right to withhold Shares
pursuant to clause (i) or to withhold from any other amounts due to you from the Company if you have not satisfied your tax withholding obligations.
		
	Restrictions on Resale	  	Unvested Shares may not be transferred by you, and the Company may take such action as it deems appropriate to enforce the foregoing. You agree not to sell any Shares when applicable laws,
Company trading policies (including the Company’s Insider Trading Policy) or an agreement between the Company and its underwriters prohibit a sale. This restriction will apply during your Service and for such period of time after the
termination of your Service as the Company may specify.
		
	No Retention Rights	  	Your award or this Agreement does not give you the right to be employed or retained by the Company or a subsidiary of the Company in any capacity. The Company and its subsidiaries reserve the
right to terminate your service at any time, with or without cause.
		
	Adjustments	  	In the event of a stock split, a stock dividend or a similar change in Company stock, the number of Shares that have not been transferred to you and remain subject to this award will be adjusted
accordingly.
		
	Applicable Law	  	This Agreement will be interpreted and enforced under the laws of the State of Delaware (without regard to their choice-of-law provisions).

  

 4 

			
	The Plan and Other Agreements	  	 The text of the Company’s 2007 New Employee Stock Incentive Plan is incorporated in this Agreement by reference. A copy of the Plan is
available on the Company’s intranet or by request to the Company’s Finance Department.
  
 This Agreement and the Plan constitute the entire understanding between you and the Company regarding this award. Any prior agreements, commitments or negotiations concerning this award are superseded. This Agreement may be amended only by
another written agreement between the parties.

 You agree to all of the terms and conditions described above and in the Company’s 2007

 New Employee Stock Incentive Plan. 
  

 5Third Amended and Restated Registration Rights Agreement

 EXHIBIT 4.2 
  

 THIRD AMENDED AND RESTATED 
 REGISTRATION RIGHTS AGREEMENT 
 by and among 
 MAP PHARMACEUTICALS, INC. 
 and 
 THE STOCKHOLDERS LISTED THEREIN 
  

 Dated: March 21, 2007 
  

  

 TABLE OF CONTENTS 
  

							
	 	  	 	  	 	  	Page
	ARTICLE I DEFINITIONS	  	2
		  	  1.1	  	Definitions	  	2
		
	ARTICLE II GENERAL; SECURITIES SUBJECT TO THIS AGREEMENT	  	6
		  	  2.1	  	Grant of Rights	  	6
		  	  2.2	  	Registrable Securities	  	6
		  	  2.3	  	Holders of Registrable Securities	  	6
		
	ARTICLE III DEMAND REGISTRATION	  	6
		  	  3.1	  	Request for Demand Registration	  	6
		  	  3.2	  	Incidental or “Piggy-Back” Rights with Respect to a Demand Registration	  	7
		  	  3.3	  	Effective Demand Registration	  	8
		  	  3.4	  	Expenses	  	8
		  	  3.5	  	Underwriting Procedures	  	8
		  	  3.6	  	Selection of Underwriters	  	9
		
	ARTICLE IV INCIDENTAL OR “PIGGY-BACK” REGISTRATION	  	9
		  	  4.1	  	Request for Incidental Registration	  	9
		  	  4.2	  	Expenses	  	10
		
	ARTICLE V FORM S-3 REGISTRATION	  	10
		  	  5.1	  	Request for a Form S-3 Registration	  	11
		  	  5.2	  	Form S-3 Underwriting Procedures	  	11
		  	  5.3	  	Limitations on Form S-3 Registrations	  	12
		  	  5.4	  	Expenses	  	12
		  	  5.5	  	No Demand Registration	  	12
		
	ARTICLE VI MARKET STANDOFF AGREEMENTS	  	12
		  	  6.1	  	Restrictions on Public Sale by Designated Holders	  	12
		  	  6.2	  	Restrictions on Public Sale by the Company	  	13
		
	ARTICLE VII REGISTRATION PROCEDURES	  	13
		  	  7.1	  	Obligations of the Company	  	13
		  	  7.2	  	Seller Information	  	16
		  	  7.3	  	Notice to Discontinue	  	16
		  	  7.4	  	Registration Expenses	  	17
		
	ARTICLE VIII INDEMNIFICATION; CONTRIBUTION	  	17
		  	  8.1	  	Indemnification by the Company	  	17
		  	  8.2	  	Indemnification by Designated Holders	  	18
		  	  8.3	  	Conduct of Indemnification Proceedings	  	18
		  	  8.4	  	Contribution	  	19
		
	ARTICLE IX COVENANTS	  	20
		  	  9.1	  	Rule 144	  	20
		  	  9.2	  	Form S-3	  	20
		
	ARTICLE X MISCELLANEOUS	  	20
		  	10.1	  	Recapitalizations, Exchanges, etc.	  	20
		  	10.2	  	No Inconsistent Agreements	  	21
		  	10.3	  	Remedies	  	21
		  	10.4	  	Notices	  	21
		  	10.5	  	Successors and Assigns; Third-Party Beneficiaries	  	22
		  	10.6	  	Amendments and Waivers	  	22
		  	10.7	  	Counterparts	  	22
		  	10.8	  	Headings	  	23
		  	10.9	  	Governing Law; Consent To Jurisdiction	  	23
		  	10.10	  	Severability	  	23
		  	10.11	  	Rules of Construction	  	23
		  	10.12	  	Entire Agreement	  	23
		  	10.13	  	Further Assurances	  	23
		  	10.14	  	Other Agreements	  	24
		  	10.15	  	Additional Parties.	  	24
		  	10.16	  	Termination of the Current Rights Agreement.	  	24

 THIRD AMENDED AND RESTATED 
 REGISTRATION RIGHTS AGREEMENT 
 THIS THIRD AMENDED AND RESTATED REGISTRATION
RIGHTS AGREEMENT (this “Agreement”), dated March 21, 2007, is by and among MAP Pharmaceuticals, Inc., a Delaware corporation (the “Company”), the investor stockholders listed on Schedule 1 hereto (the
“Investors”) and the stockholders listed on Schedule 2 hereto (the “Founding Stockholders”). 
 WHEREAS, pursuant to the Stock Purchase Agreement, dated as of the date hereof (the “Series D Stock Purchase Agreement”), by and among the Company and the Investors, the Company has agreed to issue and sell to the
Investors an aggregate of 6,989,582 shares of Series D Convertible Participating Preferred Stock, par value $0.01 per share, of the Company (the “Series D Preferred Stock”); 
 WHEREAS, pursuant to the Stock Purchase Agreement, dated as of January 19, 2006 (the “Series C Stock Purchase Agreement”), by
and among the Company and certain of the Investors, the Company issued and sold an aggregate of 6,011,904 shares of Series C Convertible Participating Preferred Stock, par value $0.01 per share, of the Company (the “Series C
Preferred Stock”) 
 WHEREAS, pursuant to the Stock Purchase Agreement, dated as of August 13, 2004 (the “Series B
Stock Purchase Agreement”), by and between the Company and certain of the Investors, the Company issued and sold an aggregate of 8,282,223 shares (after giving effect to the 9-for-1 forward stock split effected on June 16, 2005) of
Series B Convertible Participating Preferred Stock, par value $0.01 per share, of the Company (the “Series B Preferred Stock”); 
 WHEREAS, pursuant to the Stock Purchase Agreement, dated as of March 3, 2004 (the “Series A Stock Purchase Agreement”), by and between the Company and one of the Investors, the Company
issued and sold an aggregate of 1,080,000 shares (after giving effect to the 9-for-1 forward stock split effected on June 16, 2005) of Series A Convertible Participating Preferred Stock, par value $0.01 per share, of the Company
(the “Series A Preferred Stock”); 
 WHEREAS, the Company, certain of the Investors and the Founding Stockholders
are parties to that certain Second Amended and Restated Registration Rights Agreement dated as of January 19, 2006 (the “Current Rights Agreement”); 
 WHEREAS, concurrently herewith, the Company, the Investors and the Founding Stockholders (as hereinafter defined) are entering into the Restated Stockholders Agreement (as hereinafter defined), pursuant to which the
parties thereto have agreed to, among other things, certain first offer and tag-along rights, preemptive rights and certain corporate governance rights and obligations; and 
 WHEREAS, in order to induce each of the Investors to purchase its shares of Series D Preferred Stock, and to induce the parties hereto to enter into
the Restated 

 
Stockholders Agreement with respect to such shares of Preferred Stock, the Company and the parties hereto wish to amend and restate the Current Rights
Agreement in its entirety as set forth herein, and the Company agrees to grant registration rights with respect to the Registrable Securities (as hereinafter defined) as set forth in this Agreement; and 
 NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein and for good and valuable consideration, the receipt and
adequacy of which are hereby acknowledged, the parties hereto amend, restate, supersede and replace the Current Rights Agreement in its entirety and agree as follows: 
 ARTICLE I 
 DEFINITIONS 
 1.1 Definitions. As used in this Agreement, and unless the context requires a different meaning, the following terms have the meanings indicated:

 “Affiliate” shall mean any Person who is an “affiliate” as defined in Rule 12b-2 of the General Rules and
Regulations under the Exchange Act. In addition, any partner or member, as the case may be, of an Investor, and any Person under common management with an Investor, shall be deemed to be an Affiliate of such Investor. 
 “Agreement” means this Agreement as the same may be amended, supplemented or modified in accordance with the terms hereof. 

“Approved Underwriter” has the meaning set forth in Section 3.6. 
 “Board of Directors” means the board of directors of the Company. 
 “Business Day” means any day other than a Saturday, Sunday or other day on which commercial banks in the State of New York are
authorized or required by law or executive order to close. 
 “Closing Price” means, with respect to the Registrable
Securities, as of the date of determination, (a) if the Registrable Securities are listed on a national securities exchange, the closing price per share of a Registrable Security on such date published in The Wall Street Journal (National
Edition) or, if no such closing price on such date is published in The Wall Street Journal (National Edition), the average of the closing bid and asked prices on such date, as officially reported on the principal national securities
exchange on which the Registrable Securities are then listed or admitted to trading; or (b) if the Registrable Securities are not then listed or admitted to trading on any national securities exchange but are designated as national market
system securities by the NASD, the last trading price per share of a Registrable Security on such date; or (c) if there shall have been no trading on such date or if the Registrable Securities are not designated as national market system
securities by the NASD, the average of the reported closing bid and asked prices of the Registrable Securities on such date as shown by The NASDAQ 

  

 2 

 
Global Market (or its successor); or (d) if none of (a), (b) or (c) is applicable, a price per share determined in good faith by the Board of
Directors or, if such determination is not satisfactory to the Designated Holders for whom such determination is being made, by a nationally recognized investment banking firm selected by the Company and such Designated Holders, the expenses for
which shall be borne equally by the Company and such Designated Holders. If trading is conducted on a continuous basis on any exchange, then the closing price shall be at 4:00 P.M. New York City time. 
 “Commission” means the Securities and Exchange Commission or any similar agency then having jurisdiction to enforce the Securities Act.

 “Common Stock” means the Common Stock, par value $0.01 per share, of the Company or any other capital stock of the
Company into which such stock is reclassified or reconstituted and any other common stock of the Company. 
 “Company” has
the meaning set forth in the preamble to this Agreement. 
 “Company Underwriter” has the meaning set forth in
Section 4.1. 
 “Current Rights Agreement” has the meaning set forth in the recitals to this Agreement. 
 “Demand Registration” has the meaning set forth in Section 3.1. 
 “Designated Holder” means each of the Investor Stockholders, the Founding Stockholders and any transferee of any of them to whom
Registrable Securities have been transferred in accordance with Section 10.5 of this Agreement, other than a transferee to whom Registrable Securities have been transferred pursuant to an effective Registration Statement under the Securities
Act or to the public pursuant to Rule 144 under the Securities Act (or any successor rule thereto). 
 “Exchange Act” means
the United States Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder. 
 “Form S-3” means such form under the Securities Act as in effect on the date hereof or any registration form under the Securities Act subsequently adopted by the Commission which permits inclusion or incorporation of
substantial information by reference to other documents filed by the Company with the Commission. 
 “Founding Stockholders”
means the stockholders listed on Schedule 2 hereto and any Permitted Transferee (as defined in the Restated Stockholders Agreement) thereof to whom Registrable Securities are transferred in accordance with Section 2.2 of the Restated
Stockholders Agreement (so long as such agreement is in effect) and with Section 10.5 of this Agreement. 
 “Holders’
Counsel” has the meaning set forth in Section 7.1(a). 
 “Incidental Registration” has the meaning set forth
in Section 4.1. 
  

 3 

 “Indemnified Party” has the meaning set forth in Section 8.3. 
 “Indemnifying Party” has the meaning set forth in Section 8.3. 
 “Initial Public Offering” means the initial public offering of the shares of Common Stock of the Company pursuant to an effective
Registration Statement filed under the Securities Act. 
 “Initiating Holders” has the meaning set forth in
Section 3.1. 
 “Inspector” or “Inspectors” has the meaning set forth in Section 7.1(g).

 “Investors” has the meaning set forth in the preamble to this Agreement. 
 “Investor Stockholders” means each Investor and any Permitted Transferee (as defined in the Restated Stockholders Agreement) thereof to
whom Registrable Securities are transferred in accordance with Section 2.2 of the Restated Stockholders Agreement (so long as such agreement is in effect) and with Section 10.5 of this Agreement. 
 “IPO Effectiveness Date” means the date upon which the Company closes its Initial Public Offering. 
 “Liability” or “Liabilities” has the meaning set forth in Section 8.1. 
 “Market Price” means, on any date of determination, the average of the daily Closing Price of the Registrable Securities for the
immediately preceding thirty (30) days on which the national securities exchanges are open for trading, provided, however, that if the Board determines the price of the Registrable Securities pursuant to clause (d) of the
definition of Closing Price, such price shall be the Market Price. 
 “NASD” means the National Association of Securities
Dealers, Inc. 
 “Person” means any individual, firm, corporation, partnership, trust, incorporated or unincorporated
association, joint venture, joint stock company, limited liability company, government (or an agency or political subdivision thereof) or other entity of any kind, and shall include any successor (by merger or otherwise) of such entity.

 “Preferred Stock” means the Series A Preferred Stock, the Series B Preferred Stock, the Series C Preferred
Stock and the Series D Preferred Stock. 
 “Records” has the meaning set forth in Section 7.1(g). 
 “Registrable Securities” means each of the following: (a) any and all shares of Common Stock owned by the Designated Holders or
issued or issuable upon conversion of shares of Preferred Stock owned by the Designated Holders and any shares of Common Stock issued or issuable upon conversion of any shares of preferred stock or exercise of any warrants acquired by any of the
Designated Holders after the date hereof, (b) any other shares of Common Stock acquired or owned by any of the Designated 

  

 4 

 
Holders prior to the IPO Effectiveness Date, or acquired or owned by any of the Designated Holders after the IPO Effectiveness Date if such Designated Holder
is an Affiliate of the Company and (c) any shares of Common Stock issued or issuable to any of the Designated Holders with respect to the Registrable Securities by way of stock dividend or stock split or in connection with a combination of
shares, recapitalization, merger, consolidation or other reorganization or otherwise and any shares of Common Stock issuable upon conversion, exercise or exchange thereof. 
 “Registration Expenses” has the meaning set forth in Section 7.4. 
 “Registration Statement” means a registration statement filed pursuant to the Securities Act. 
 “Restated Stockholders Agreement” means the Third Amended and Restated Stockholders Agreement, dated the date hereof, among the Company,
the Investors and the Founding Stockholders. 
 “S-3 Initiating Holders” has the meaning set forth in Section 5.1 of
this Agreement. 
 “S-3 Registration” has the meaning set forth in Section 5.1. 
 “Securities Act” means the United States Securities Act of 1933, as amended, and the rules and regulations of the Commission
promulgated thereunder. 
 “Series A Preferred Stock” has the meaning set forth in the recitals to this Agreement.

 “Series A Stock Purchase Agreement” has the meaning set forth in the recitals to this Agreement. 
 “Series B Preferred Stock” has the meaning set forth in the recitals to this Agreement. 
 “Series B Stock Purchase Agreement” has the meaning set forth in the recitals to this Agreement. 
 “Series C Preferred Stock” has the meaning set forth in the recitals to this Agreement. 
 “Series C Stock Purchase Agreement” has the meaning set forth in the recitals to this Agreement. 
 “Series D Preferred Stock” has the meaning set forth in the recitals to this Agreement. 
 “Series D Stock Purchase Agreement” has the meaning set forth in the recitals to this Agreement. 
  

 5 

 “Valid Business Reason” has the meaning set forth in Section 3.1. 
 ARTICLE II 
 GENERAL; SECURITIES
SUBJECT TO THIS AGREEMENT 
 2.1 Grant of Rights. The Company hereby grants registration rights to the Designated Holders upon the
terms and conditions set forth in this Agreement. 
 2.2 Registrable Securities. For the purposes of this Agreement, Registrable
Securities will cease to be Registrable Securities when (i) a Registration Statement covering such Registrable Securities has been declared effective under the Securities Act by the Commission and such Registrable Securities have been disposed
of pursuant to such effective Registration Statement, (ii) (x) the entire amount of the Registrable Securities owned by a Designated Holder may then be sold on any one day pursuant to Rule 144 promulgated under the Securities Act and
(y) such Designated Holder owning such Registrable Securities owns less than one percent (1%) of the outstanding shares of Common Stock on a fully diluted basis or (iii) the Registrable Securities are proposed to be sold or
distributed by a Person not entitled to the registration rights granted by this Agreement. 
 2.3 Holders of Registrable Securities. A
Person is deemed to be a holder of Registrable Securities whenever such Person owns of record Registrable Securities, or holds an option to purchase, or a security convertible into or exercisable or exchangeable for, Registrable Securities
whether or not such acquisition or conversion has actually been effected. If the Company receives conflicting instructions, notices or elections from two or more Persons with respect to the same Registrable Securities, the Company may act upon the
basis of the instructions, notice or election received from the registered owner of such Registrable Securities. Registrable Securities issuable upon exercise of an option or upon conversion of another security shall be deemed
outstanding for the purposes of this Agreement. 
 ARTICLE III 
 DEMAND REGISTRATION 
 3.1 Request for Demand Registration. Upon the
earlier of (i) six (6) months after the IPO Effectiveness Date and (ii) September 30, 2008, Investor Stockholders holding at least 25% of the Registrable Securities then held by all of the Investor Stockholders (the
“Initiating Holders”) and proposing to sell their Registrable Securities at an aggregate price (calculated based upon the Market Price of the Registrable Securities on the date of the delivery of their request for demand
registration) to the public of not less than $10,000,000, may make a written request to the Company to register, and the Company shall register, under the Securities Act (other than pursuant to a Registration Statement on Form S-4 or S-8 or any
successor thereto) (a “Demand Registration”), the number of Registrable Securities stated in such request; provided, however, that the Company shall not be obligated to effect more than two (2) such 
  

 6 

 
Demand Registrations for the Investor Stockholders and provided, further, that, if such Demand Registration shall result in an Initial Public Offering, such
written request must be made by Investor Stockholders holding more than 50% of the Registrable Securities then held by all of the Investor Stockholders and proposing to sell their Registrable Securities at an aggregate price (calculated based upon
the Market Price of the Registrable Securities on the date of the delivery of their request for demand registration) to the public of not less than $15,000,000. If the Board of Directors, in its good faith judgment, determines that any registration
of Registrable Securities should not be made or continued because (i) in the case of a demand that would cause the Initial Public Offering, it would require the Company to make public disclosure of information, the public disclosure of which
would have a material adverse effect upon the Company or (ii) it would materially interfere with any material financing, acquisition, corporate reorganization or merger or other material transaction involving the Company (a “Valid
Business Reason”), the Company may (x) postpone filing a registration statement relating to a Demand Registration until such Valid Business Reason no longer exists, but in no event for more than ninety (90) days, and (y) in
case a registration statement has been filed relating to a Demand Registration, if the Valid Business Reason has not resulted from actions taken by the Company, the Company, upon the approval of a majority of the Board of Directors, may cause such
registration statement to be withdrawn and its effectiveness terminated or may postpone amending or supplementing such registration statement. The Company shall give written notice of its determination to postpone or withdraw, but in no event for
more than ninety (90) days, a registration statement and of the fact that the Valid Business Reason for such postponement or withdrawal no longer exists, in each case, promptly after the occurrence thereof. Notwithstanding anything to the
contrary contained herein, the Company may not postpone or withdraw a filing under this Section 3.1 more than once in any twelve (12) month period. Each request for a Demand Registration by the Initiating Holders shall state the amount of
the Registrable Securities proposed to be sold and the intended method of disposition thereof. 
 3.2 Incidental or “Piggy-Back”
Rights with Respect to a Demand Registration. Each of the Designated Holders (other than Initiating Holders which have requested a registration under Section 3.1) may offer its Registrable Securities under any Demand Registration pursuant
to this Section 3.2. Within five (5) days after the receipt of a request for a Demand Registration from an Initiating Holder, the Company shall (i) give written notice thereof to all of the Designated Holders (other than
Initiating Holders which have requested a registration under Section 3.1) and (ii) subject to Section 3.5, include in such registration all of the Registrable Securities held by such Designated Holders from whom the Company has
received a written request for inclusion therein within fifteen (15) days of the receipt by such Designated Holders of such written notice referred to in clause (i) above. Each such request by such Designated Holders shall specify the
number of Registrable Securities proposed to be registered. The failure of any Designated Holder to respond within such 15-day period referred to in clause (ii) above shall be deemed to be a waiver of such Designated Holder’s rights
under this Article III with respect to such Demand Registration. Any Designated Holder may waive its rights under this Article III prior to the expiration of such 15-day period by giving written notice to the Company, with a copy to the
Initiating Holders. If a Designated 
  

 7 

 
Holder sends the Company a written request for inclusion of part or all of such Designated Holder’s Registrable Securities in a registration, such
Designated Holder shall not be entitled to withdraw or revoke such request without the prior written consent of the Company in its sole discretion unless, as a result of facts or circumstances arising after the date on which such request was made
relating to the Company or to market conditions, such Designated Holder reasonably determines that participation in such registration would have a material adverse effect on such Designated Holder. 
 3.3 Effective Demand Registration. 
 (a) The Company shall use its reasonable best efforts to cause any such Demand Registration to become and remain effective as soon as reasonably practicable, and in no event more than ninety (90) days, after it receives a request under
Section 3.1 hereof. A registration shall not constitute a Demand Registration until it has become effective and remains continuously effective for the lesser of (i) the period during which all Registrable Securities registered in the
Demand Registration are sold and (ii) 120 days; provided, however, that a registration shall not constitute a Demand Registration if (x) after such Demand Registration has become effective, such registration or the related offer, sale
or distribution of Registrable Securities thereunder is interfered with by any stop order, injunction or other order or requirement of the Commission or other governmental agency or court for any reason not attributable to the Initiating Holders and
such interference is not thereafter eliminated or (y) the conditions specified in the underwriting agreement, if any, entered into in connection with such Demand Registration are not satisfied or waived, other than by reason of a failure by the
Initiating Holder. 
 (b) Notwithstanding anything set forth elsewhere herein, if any registration prepared by the Company at the
request of Initiating Holders pursuant to this Article III is not filed or does not become effective as a result of the decision of the Initiating Holders or any underwriter designated by them other than because of the Company’s failure to
comply with its obligations hereunder, because of a material adverse change in the Company’s business or another reason primarily attributable to the Company, and the Investor Stockholders elect not to pay all of the Registration Expenses
incurred in connection with such registration request, then such registration shall count as one of the two Demand Registrations that the Investor Stockholders may make pursuant to Section 3.1. 
 3.4 Expenses. The Company shall pay all Registration Expenses in connection with a Demand Registration, whether or not such Demand Registration
becomes effective. 
 3.5 Underwriting Procedures. If the Company or the Initiating Holders holding a majority of the Registrable
Securities held by all of the Initiating Holders so elect, the Company shall use its reasonable best efforts to cause such Demand Registration to be in the form of a firm commitment underwritten offering and the managing underwriter or underwriters
selected for such offering shall be the Approved 
  

 8 

 
Underwriter selected in accordance with Section 3.6. In connection with any Demand Registration under this Article III involving an underwritten
offering, none of the Registrable Securities held by any Designated Holder making a request for inclusion of such Registrable Securities pursuant to Section 3.2 hereof shall be included in such underwritten offering unless such Designated
Holder accepts the terms of the offering as agreed upon by the Company, the Initiating Holders and the Approved Underwriter, and then only in such quantity as will not, in the opinion of the Approved Underwriter, jeopardize the success of such
offering by the Initiating Holders. If the Approved Underwriter advises the Company that the aggregate amount of such Registrable Securities requested to be included in such offering is sufficiently large to have a material adverse effect on the
success of such offering, then the Company shall include in such registration only the aggregate amount of Registrable Securities that the Approved Underwriter believes may be sold without any such material adverse effect and shall reduce the amount
of Registrable Securities to be included in such registration, with such reduction applying first as to the Company, second as to the Founding Stockholders who request to participate in such registration pursuant to Section 3.2 hereof as a
group, third as to the Investor Stockholders who are not Initiating Holders and who request to participate in such registration pursuant to Section 3.2 hereof as a group, and fourth as to the Initiating Holders as a group, pro rata within each
group based on the number of Registrable Securities owned by each such holder of Registrable Securities, as the case may be. 
 3.6
Selection of Underwriters. If any Demand Registration or S-3 Registration, as the case may be, of Registrable Securities is in the form of an underwritten offering, the Company shall select and obtain an investment banking firm of national
reputation to act as the managing underwriter of the offering (the “Approved Underwriter”); provided, however, that the Approved Underwriter shall, in any case, also be approved by Initiating Holders or S-3 Initiating Holders,
as the case may be, holding a majority of the Registrable Securities held by such Initiating Holders or S-3 Initiating Holders, as applicable, such approval not to be unreasonably withheld. 
 ARTICLE IV 
 INCIDENTAL OR “PIGGY-BACK” REGISTRATION 

4.1 Request for Incidental Registration. If the Company proposes to file a Registration Statement under the Securities Act with respect to
an offering by the Company of its equity securities for cash for its own account (other than (a) a Registration Statement in which the only equity securities being registered are equity securities issuable upon conversion of debt securities
which are also being registered, (b) a Registration Statement on Form S-4 or Form S-8, or any successor thereto, or otherwise primarily in connection with a Company stock incentive plan, or (c) a Registration Statement in connection with
an exchange offer of securities solely to existing security holders of the Company, or (d) a Registration Statement relating to a transaction under Rule 145 of the Securities Act) or for the account of any stockholder of the Company other than
the Designated Holders, then the Company shall give written 
  

 9 

 
notice of such proposed filing to each of the Designated Holders at least twenty (20) days before the anticipated filing date, and such notice shall
describe the proposed registration and distribution and offer such Designated Holders the opportunity to register the number of Registrable Securities as each such Designated Holders may request (an “Incidental Registration”). The
Company shall use its reasonable best efforts (within twenty (20) days of the notice provided for in the preceding sentence) to cause the managing underwriter or underwriters in the case of a proposed underwritten offering (the “Company
Underwriter”) to permit each of the Designated Holders who have requested in writing to participate in the Incidental Registration to include its, his or her Registrable Securities in such offering on the same terms and conditions as the
securities of the Company or the account of such other stockholder, as the case may be, included therein, provided that (other than as set forth in Articles III and V and as may be otherwise set forth in this Article IV) the Company shall have the
right to postpone or withdraw, in its sole discretion, any such registration without obligation to any Designated Holder. In connection with any Incidental Registration under this Section 4.1 involving an underwritten offering, the Company
shall not be required to include any Registrable Securities in such underwritten offering unless the Designated Holders accept the terms of the underwritten offering as agreed upon between the Company, such other stockholders, if any, and the
Company Underwriter, and then, subject to the following two sentences, only in such quantity as the Company Underwriter believes will not jeopardize the success of the offering by the Company. If the Company Underwriter determines that the
registration of all or part of the Registrable Securities which the Investor Stockholders have requested to be included would materially adversely affect the success of such offering, then the Company shall be required to include in such Incidental
Registration, to the extent of the amount that the Company Underwriter believes may be sold without causing such material adverse effect, first, all of the securities to be offered for the account of the Company; second, the Registrable Securities
to be offered for the account of the Investor Stockholders pursuant to this Article IV, pro rata based on the number of Registrable Securities owned by each such Investor Stockholder; third, the Registrable Securities to be offered for the account
of the Founding Stockholders pursuant to this Article IV, pro rata based on the number of Registrable Securities owned by each such Founding Stockholder; and fourth, any other securities requested to be included in such offering; provided, however,
that no such reduction shall reduce the number of shares of Registrable Securities to be offered for the account of Investor Stockholders below 30% of the total number of shares included in the Incidental Registration. Notwithstanding the foregoing,
if such offering is the Initial Public Offering, any or all of the Registrable Securities held by the Investor Stockholders may be excluded if the underwriters make the determination described above. 
 4.2 Expenses. The Company shall bear all Registration Expenses in connection with any Incidental Registration pursuant to this Article IV, whether
or not such Incidental Registration becomes effective. 
  

 10 

 ARTICLE V 
 FORM S-3 REGISTRATION 
 5.1 Request for a Form S-3 Registration. Upon the Company becoming
eligible for use of Form S-3 (or any successor form thereto) under the Securities Act in connection with a public offering of its securities, in the event that the Company shall receive from Investor Stockholders holding 25% of the Registrable
Securities then held by all of the Investor Stockholders (the “S-3 Initiating Holders”) and proposing to sell their Registrable Securities at an aggregate price (calculated based upon the Market Price of the Registrable Securities
on the date of the delivery of their request for demand registration) to the public of not less than $2,000,000, a written request that the Company register, under the Securities Act on Form S-3 (or any successor form then in effect)
(an “S-3 Registration”), all or a portion of the Registrable Securities owned by such S-3 Initiating Holders, the Company shall give written notice of such request to all of the Designated Holders (other than S-3 Initiating
Holders which have requested an S-3 Registration under this Section 5.1) at least ten (10) days before the anticipated filing date of such Form S-3, and such notice shall describe the proposed registration and offer such Designated Holders
the opportunity to register the number of Registrable Securities as each such Designated Holder may request in writing to the Company, given within ten (10) days after their receipt from the Company of the written notice of such registration;
provided, however, that the Company shall not be required to effect more than two S-3 Registrations in any twelve (12) month period. If requested by the S-3 Initiating Holders such S-3 Registration shall be for an offering on a
continuous basis pursuant to Rule 415 under the Securities Act. With respect to each S-3 Registration, the Company shall, subject to Section 5.2, (i) include in such offering the Registrable Securities of the S-3 Initiating Holders and
(ii) use its reasonable best efforts to (x) cause such registration pursuant to this Section 5.1 to become and remain effective within forty-five (45) days after it receives a request therefor; provided, however, that if during
the ten (10) day period prior to the expiration of such forty-five (45) day period the Company receives comments from the Commission on the filed Form S-3 or any other registration statements under the Securities Act or reports under the
Exchange Act it has filed with the Commission, then the forty-five (45) day period in this clause (x) is extended to fifty-five (55) days, and (y) include in such offering the Registrable Securities of the Designated Holders
(other than S-3 Initiating Holders which have requested an S-3 Registration under this Section 5.1) who have requested in writing to participate in such registration on the same terms and conditions as the Registrable Securities of the S-3
Initiating Holders included therein. 
 5.2 Form S-3 Underwriting Procedures. If the S-3 Initiating Holders holding a majority of the
Registrable Securities held by all of the S-3 Initiating Holders so elect, the Company shall use its reasonable best efforts to cause such S-3 Registration pursuant to this Article V to be in the form of a firm commitment underwritten offering and
the managing underwriter or underwriters selected for such offering shall be the Approved Underwriter selected in accordance with Section 3.6. In connection with any S-3 Registration under Section 5.1 involving an underwritten
offering, the Company shall not be required to include any Registrable Securities in such underwritten offering unless the Designated Holders thereof accept the terms of the underwritten offering as agreed upon between the Company, the Approved
Underwriter and the S-3 Initiating Holders, and then only in such quantity as such underwriter believes will not jeopardize the success of 
  

 11 

 
such offering by the S-3 Initiating Holders. If the Approved Underwriter believes that the registration of all or part of the Registrable Securities which
the S-3 Initiating Holders and the other Designated Holders have requested to be included would materially adversely affect the success of such public offering, then the Company shall be required to include in the underwritten offering, to the
extent of the amount that the Approved Underwriter believes may be sold without causing such material adverse effect, first, all of the Registrable Securities to be offered for the account of the S-3 Initiating Holders, pro rata based on the
number of Registrable Securities owned by such S-3 Initiating Holders; second, the Registrable Securities to be offered for the account of the other Designated Holders who requested inclusion of their Registrable Securities pursuant to
Section 5.1, pro rata based on the number of Registrable Securities owned by such Designated Holders; and third, any other securities requested to be included in such offering. 
 5.3 Limitations on Form S-3 Registrations. If the Board of Directors has a Valid Business Reason, the Company may (x) postpone filing a
registration statement relating to a S-3 Registration until such Valid Business Reason no longer exists, but in no event for more than ninety (90) days, and (y) in case a registration statement has been filed relating to a S-3
Registration, if the Valid Business Reason has not resulted from actions taken by the Company, the Company, upon the approval of a majority of the Board of Directors, may cause such registration statement to be withdrawn and its effectiveness
terminated or may postpone amending or supplementing such registration statement. The Company shall give written notice of its determination to postpone or withdraw a registration statement and of the fact that the Valid Business Reason for such
postponement or withdrawal no longer exists, in each case, promptly after the occurrence thereof. Notwithstanding anything to the contrary contained herein, the Company may not postpone or withdraw a filing due to a Valid Business Reason more than
once in any twelve (12) month period. In addition, the Company shall not be required to effect any registration pursuant to Section 5.1 (i) within ninety (90) days after the effective date of any other Registration Statement of
the Company, or (ii) if Form S-3 is not available for such offering by the S-3 Initiating Holders. 
 5.4 Expenses. The Company
shall bear all Registration Expenses in connection with any S-3 Registration pursuant to this Article V, whether or not such S-3 Registration becomes effective. 
 5.5 No Demand Registration. No registration requested by any S-3 Initiating Holder pursuant to this Article V shall be deemed a Demand Registration pursuant to Article III. 
 ARTICLE VI 
 MARKET STANDOFF
AGREEMENTS 
 6.1 Restrictions on Public Sale by Designated Holders. In connection with the Company’s Initial Public
Offering, to the extent (i) requested by the Company and the Company Underwriter and (ii) all of the Company’s officers, directors and holders in 
  

 12 

 
excess of one percent (1%) of its outstanding capital stock execute agreements identical to those referred to in this Section 6.1, each Designated
Holder of Registrable Securities agrees (x) not to effect any public sale or distribution of any Registrable Securities or of any securities convertible into or exchangeable or exercisable for such Registrable Securities, including a sale
pursuant to Rule 144 under the Securities Act, or offer to sell, contract to sell (including, without limitation, by means of a short sale), grant any option to purchase or enter into any hedging or similar transaction with the same economic effect
as a sale of Registrable Securities and (y) not to make any request for a Demand Registration or S-3 Registration under this Agreement, during the 180-day period beginning on the effective date of the Registration Statement (except as part of
such registration) for the Initial Public Offering (or such longer period, not to exceed eighteen (18) days after the expiration of such 180 day period, as the Company Underwriter or the Company shall request in order to facilitate compliance
with NASD Rule 2711). 
 6.2 Restrictions on Public Sale by the Company. The Company agrees not to effect any public sale or
distribution of any of its securities, or any securities convertible into or exchangeable or exercisable for such securities (except pursuant to registrations on Form S-4 or S-8 or any successor thereto), during the period beginning on the
effective date of any Registration Statement relating to the offering in which the Designated Holders of Registrable Securities are participating and ending on the earlier of (i) the date on which all Registrable Securities registered pursuant
to such Registration Statement are sold and (ii) 120 days after the effective date of such Registration Statement (except as part of such registration). 
 ARTICLE VII 
 REGISTRATION PROCEDURES 
 7.1 Obligations of the Company. Whenever registration of Registrable Securities has been requested pursuant to Article III, Article IV or
Article V of this Agreement, the Company shall use its reasonable best efforts to effect the registration and sale of such Registrable Securities in accordance with the intended method of distribution thereof as quickly as practicable, and in
connection with any such request, the Company shall, as expeditiously as possible: 
 (a) prepare and file with the Commission a Registration
Statement on any form for which the Company then qualifies or which counsel for the Company shall deem appropriate and which form shall be available for the sale of such Registrable Securities in accordance with the intended method of distribution
thereof, and cause such Registration Statement to become effective; provided, however, that (x) before filing a Registration Statement or prospectus or any amendments or supplements thereto, the Company shall provide counsel
selected by the Designated Holders holding a majority of the Registrable Securities being registered in such registration (“Holders’ Counsel”) and any other Inspector with an adequate and appropriate opportunity to review
and comment on such Registration Statement and each prospectus included therein (and each amendment or supplement thereto) to be filed with the Commission, subject to such documents being under the Company’s control, and 

  

 13 

 
(y) the Company shall notify the Holders’ Counsel and each seller of Registrable Securities of any stop order issued or threatened by the
Commission and take all action required to prevent the entry of such stop order or to remove it if entered; 
 (b) prepare and file with the
Commission such amendments and supplements to such Registration Statement and the prospectus used in connection therewith as may be necessary to keep such Registration Statement effective for the lesser of (x) 120 days and (y) such
shorter period which will terminate when all Registrable Securities covered by such Registration Statement have been sold; provided, that if the S-3 Initiating Holders have requested that an S-3 Registration be for an offering on a continuous
basis pursuant to Rule 415 under the Securities Act, then the Company shall use reasonable best efforts to keep such Registration Statement effective until all Registrable Securities covered by such Registration Statement have been sold; and shall
comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such Registration Statement during such period in accordance with the intended methods of disposition by the sellers thereof set forth in
such Registration Statement; 
 (c) furnish to each seller of Registrable Securities, prior to filing a Registration Statement, at least one
copy of such Registration Statement as is proposed to be filed, and thereafter such number of copies of such Registration Statement, each amendment and supplement thereto (in each case including all exhibits thereto), and the prospectus included in
such Registration Statement (including each preliminary prospectus) and any prospectus filed under Rule 424 under the Securities Act as each such seller may reasonably request in order to facilitate the disposition of the Registrable Securities
owned by such seller; 
 (d) register or qualify such Registrable Securities under such other securities or “blue sky” laws of such
jurisdictions as any seller of Registrable Securities may request, and to continue such qualification in effect in such jurisdiction for as long as permissible pursuant to the laws of such jurisdiction, or for as long as any such seller
requests or until all of such Registrable Securities are sold, whichever is shortest, and do any and all other acts and things which may be reasonably necessary or advisable to enable any such seller to consummate the disposition in such
jurisdictions of the Registrable Securities owned by such seller; provided, however, that the Company shall not be required to (x) qualify generally to do business in any jurisdiction where it would not otherwise be required to
qualify but for this Section 7.1(d), or (y) subject itself to taxation in any such jurisdiction or (z) consent to general service of process in any such jurisdiction; 
 (e) notify each seller of Registrable Securities at any time when a prospectus relating thereto is required to be delivered under the Securities
Act, upon discovery that, or upon the happening of any event as a result of which, the prospectus included in such Registration Statement contains an untrue statement of a material fact or omits to state any material fact required to be stated
therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading and the Company shall promptly prepare a supplement or 

  

 14 

 
amendment to such prospectus and furnish to each seller of Registrable Securities a reasonable number of copies of such supplement to or amendment of such
prospectus as may be necessary so that, after delivery to the purchasers of such Registrable Securities, such prospectus shall not contain an untrue statement of a material fact or omit to state any material fact required to be stated therein or
necessary to make the statements therein, in light of the circumstances under which they were made, not misleading; 
 (f) enter into and
perform customary agreements (including an underwriting agreement in customary form with the Approved Underwriter or Company Underwriter, if any, selected as provided in Article III, Article IV or Article V, as the case may be) and take such other
actions as are prudent and reasonably required in order to expedite or facilitate the disposition of such Registrable Securities, including causing its officers to participate in “road shows” and other information meetings organized by the
Approved Underwriter or Company Underwriter; 
 (g) make available at reasonable times for inspection by any seller of Registrable
Securities, any managing underwriter participating in any disposition of such Registrable Securities pursuant to a Registration Statement, Holders’ Counsel and any attorney, accountant or other agent retained by any such seller or any managing
underwriter (each, an “Inspector” and collectively, the “Inspectors”), all financial and other records, pertinent corporate documents and properties of the Company and its subsidiaries (collectively, the
“Records”) as shall be reasonably necessary to enable them to exercise their due diligence responsibility, and cause the Company’s and its subsidiaries’ officers, directors and employees, and the independent public
accountants of the Company, to supply all information reasonably requested by any such Inspector in connection with such Registration Statement. Records that the Company determines, in good faith, to be confidential and which it notifies the
Inspectors are confidential shall not be disclosed by the Inspectors (and the Inspectors shall confirm their agreement in writing in advance to the Company if the Company shall so request) unless (x) the disclosure of such Records is necessary,
in the Company’s judgment, to avoid or correct a misstatement or omission in the Registration Statement, (y) the release of such Records is ordered pursuant to a subpoena or other order from a court of competent jurisdiction after
exhaustion of all appeals therefrom or (z) the information in such Records was known to the Inspectors on a non-confidential basis prior to its disclosure by the Company or has been made generally available to the public. Each seller of
Registrable Securities agrees that it shall, upon learning that disclosure of such Records is sought in a court of competent jurisdiction, give notice to the Company and allow the Company, at the Company’s expense, to undertake appropriate
action to prevent disclosure of the Records deemed confidential; 
 (h) if such sale is pursuant to an underwritten offering, obtain
“cold comfort” letters dated the effective date of the registration statement and the date of the closing under the underwriting agreement from the Company’s independent public accountants in customary form and covering such matters
of the type customarily covered by “cold comfort” letters as Holders’ Counsel or the managing underwriter reasonably requests; 
  

 15 

 (i) furnish, at the request of any seller of Registrable Securities on the date such securities are
delivered to the underwriters for sale pursuant to such registration or, if such securities are not being sold through underwriters, on the date the Registration Statement with respect to such securities becomes effective, an opinion, dated such
date, of counsel representing the Company for the purposes of such registration, addressed to the underwriters, if any, and to the seller making such request, covering such legal matters with respect to the registration in respect of which such
opinion is being given as the underwriters, if any, and such seller may reasonably request and are customarily included in such opinions; 
 (j) comply with all applicable rules and regulations of the Commission, and make available to its security holders, as soon as reasonably practicable but no later than fifteen (15) months after the effective date of the
Registration Statement, an earnings statement covering a period of twelve (12) months beginning after the effective date of the Registration Statement, in a manner which satisfies the provisions of Section 11(a) of the Securities Act and
Rule 158 thereunder; 
 (k) cause all such Registrable Securities to be listed on each securities exchange on which similar securities issued
by the Company are then listed, provided that the applicable listing requirements are satisfied; 
 (l) keep Holders’ Counsel
advised in writing as to the initiation and progress of any registration under Article III, Article IV or Article V hereunder; 
 (m)
cooperate with each seller of Registrable Securities and each underwriter participating in the disposition of such Registrable Securities and their respective counsel in connection with any filings required to be made with the NASD; and 

(n) take all other steps reasonably necessary to effect the registration of the Registrable Securities contemplated hereby. 
 7.2 Seller Information. The Company may require, as a condition to each seller’s rights hereunder, that such seller of Registrable Securities
furnish to the Company such information regarding the distribution of such securities as the Company may from time to time reasonably request in writing and such other information to the extent required by law for use in connection with the
Registration Statement or prospectus in which such seller’s Registrable Securities are proposed to be included. 
 7.3 Notice to
Discontinue. Each Designated Holder agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 7.1(e), such Designated Holder shall use commercially reasonable efforts to
discontinue disposition of Registrable Securities pursuant to the Registration Statement covering such Registrable Securities until such Designated Holder’s receipt of the copies of the supplemented or amended prospectus contemplated
by Section 7.1(e) and, if so directed by the Company, such Designated Holder shall deliver to the Company (at the 
  

 16 

 
Company’s expense) all copies, other than permanent file copies then in such Designated Holder’s possession, of the prospectus covering such
Registrable Securities which is current at the time of receipt of such notice. If the Company shall give any such notice, the Company shall extend the period during which such Registration Statement shall be maintained effective pursuant to this
Agreement (including, without limitation, the period referred to in Section 7.1(b)) by the number of days during the period from and including the date of the giving of such notice pursuant to Section 7.1(e) to and including the date when
sellers of such Registrable Securities under such Registration Statement shall have received the copies of the supplemented or amended prospectus contemplated by and meeting the requirements of Section 7.1(e). 
 7.4 Registration Expenses. The Company shall pay all expenses arising from or incident to its performance of, or compliance with, this
Agreement, including, without limitation, (i) Commission, stock exchange and NASD registration and filing fees, (ii) all fees and expenses incurred in complying with securities or “blue sky” laws (including reasonable fees,
charges and disbursements of counsel to any underwriter incurred in connection with “blue sky” qualifications of the Registrable Securities as may be set forth in any underwriting agreement), (iii) all printing, messenger and delivery
expenses, (iv) the fees, charges and disbursements of counsel to the Company and of its independent public accountants and any other accounting fees, charges and expenses incurred by the Company (including, without limitation, any
expenses arising from any “cold comfort” letters or any special audits incident to or required by any registration or qualification), (v) the reasonable fees, charges and disbursements of one counsel to the Designated Holders of
Registrable Securities and (vi) any liability insurance or other premiums for insurance obtained in connection with any Demand Registration or piggy-back registration thereon, Incidental Registration or S-3 Registration pursuant to the terms of
this Agreement, regardless of whether such Registration Statement is declared effective. All of the expenses described in the preceding sentence of this Section 7.4 are referred to herein as “Registration Expenses.” The
Designated Holders of Registrable Securities sold pursuant to a Registration Statement shall bear the expense of any broker’s commission, underwriter’s discount or commission or other selling commissions relating to registration and sale
of such Designated Holders’ Registrable Securities and stock transfer taxes and, subject to clause (v) above, shall bear the fees and expenses of their own counsel. 
 ARTICLE VIII 
 INDEMNIFICATION; CONTRIBUTION 
 8.1 Indemnification by the Company. The Company agrees to indemnify and hold harmless each Designated Holder, its partners, directors,
officers and affiliates and each Person who controls or is alleged to control (within the meaning of Section 15 of the Securities Act) such Designated Holder from and against any and all losses, claims, damages, liabilities and expenses
(including reasonable costs of investigation) (each, a “Liability” and collectively, “Liabilities”), arising out of or based upon any untrue, or allegedly untrue, statement of a material fact contained in any
Registration Statement, 
  

 17 

 
prospectus, preliminary prospectus, free-writing prospectus or notification or offering circular (as amended or supplemented if the Company shall have
furnished any amendments or supplements thereto) or arising out of or based upon any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading under the
circumstances such statements were made, except insofar as such Liability arises out of or is based upon any untrue statement or alleged untrue statement or omission or alleged omission contained in such Registration Statement, preliminary
prospectus, free-writing prospectus or final prospectus in reliance and in conformity with information concerning such Designated Holder furnished in writing to the Company by such Designated Holder expressly for use therein, including, without
limitation, the information furnished to the Company pursuant to Section 8.2. The Company shall also provide customary indemnities to any underwriters of the Registrable Securities, their officers, directors and employees and each Person who
controls such underwriters (within the meaning of Section 15 of the Securities Act) to the same extent as provided above with respect to the indemnification of the Designated Holders of Registrable Securities. 
 8.2 Indemnification by Designated Holders. In connection with any Registration Statement in which a Designated Holder is participating pursuant to
Article III, Article IV or Article V hereof, each such Designated Holder agrees to indemnify and hold harmless the Company, its directors, officers and affiliates, any underwriter retained by the Company and each Person who controls the Company
or such underwriter (within the meaning of Section 15 of the Securities Act) to the same extent as the foregoing indemnity from the Company to the Designated Holders, but only if such statement or alleged statement or omission was made in
reliance upon and in conformity with information with respect to such Designated Holder furnished in writing to the Company by such Designated Holder expressly for use in such registration statement or prospectus; provided, however, that the total
amount to be indemnified by such Designated Holder pursuant to this Section 8.2 shall be limited to the net proceeds received by such Designated Holder in the offering to which the Registration Statement or prospectus relates. 
 8.3 Conduct of Indemnification Proceedings. Any Person entitled to indemnification hereunder (the “Indemnified Party”) agrees to
give prompt written notice to the indemnifying party (the “Indemnifying Party”) after the receipt by the Indemnified Party of any written notice of the commencement of any action, suit, proceeding or investigation or threat thereof
made in writing for which the Indemnified Party intends to claim indemnification or contribution pursuant to this Agreement; provided, however, that the failure to notify the Indemnifying Party shall not relieve the Indemnifying Party of any
Liability that it may have to the Indemnified Party hereunder (except to the extent that the Indemnifying Party is materially prejudiced or otherwise forfeits substantive rights or defenses by reason of such failure). If notice of commencement of
any such action is given to the Indemnifying Party as above provided, the Indemnifying Party shall be entitled to participate in and, to the extent it may wish, jointly with any other Indemnifying Party similarly notified, to assume the defense
of such action at its own expense, with counsel chosen by it and reasonably satisfactory to such Indemnified 
  

 18 

 
Party. The Indemnified Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and
expenses of such counsel shall be paid by the Indemnified Party unless (i) the Indemnifying Party agrees to pay the same, (ii) the Indemnifying Party fails to assume the defense of such action with counsel reasonably satisfactory to the
Indemnified Party or (iii) the named parties to any such action (including any impleaded parties) include both the Indemnifying Party and the Indemnified Party and such parties have been advised by such counsel that either
(x) representation of such Indemnified Party and the Indemnifying Party by the same counsel would be inappropriate under applicable standards of professional conduct or (y) there may be one or more legal defenses available to the
Indemnified Party which are different from or additional to those available to the Indemnifying Party. In any of such cases, the Indemnifying Party shall not have the right to assume the defense of such action on behalf of such Indemnified Party, it
being understood, however, that the Indemnifying Party shall not be liable for the fees and expenses of more than one separate firm of attorneys (in addition to any local counsel) for all Indemnified Parties. No Indemnifying Party shall be liable
for any settlement entered into without its written consent, which consent shall not be unreasonably withheld. No Indemnifying Party shall, without the consent of such Indemnified Party, effect any settlement of any pending or threatened proceeding
in respect of which such Indemnified Party is a party and indemnity has been sought hereunder by such Indemnified Party, unless such settlement includes an unconditional release of such Indemnified Party from all liability for claims that are the
subject matter of such proceeding. 
 8.4 Contribution. If the indemnification provided for in this Article VIII from the
Indemnifying Party is unavailable to an Indemnified Party hereunder in respect of any Liabilities referred to herein, then the Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid or payable by such
Indemnified Party as a result of such Liabilities in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions which resulted in such Liabilities, as well as any
other relevant equitable considerations. The relative faults of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement
of a material fact or omission or alleged omission to state a material fact, has been made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties’ relative intent, knowledge, access to
information and opportunity to correct or prevent such action. The amount paid or payable by a party as a result of the Liabilities referred to above shall be deemed to include, subject to the limitations set forth in Sections 8.1, 8.2 and
8.3, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding; provided that the total amount to be contributed by any Designated Holder shall be limited to the net proceeds
received by such Designated Holder in the offering. 
 The parties hereto agree that it would not be just and equitable if contribution
pursuant to this Section 8.4 were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred 

  

 19 

 
to in the immediately preceding paragraph. No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act)
shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. 
 ARTICLE IX 
 COVENANTS 
 9.1 Rule 144. The
Company covenants that from and after the IPO Effectiveness Date, but only for so long as the Company has a class of securities registered under Section 12 of the Exchange Act, it shall (a) use its reasonable best efforts to file any
reports required to be filed by it under the Exchange Act and (b) take such further action as each Designated Holder of Registrable Securities may reasonably request (including providing any information necessary to comply with Rule 144
under the Securities Act), all to the extent required from time to time to enable such Designated Holder to sell Registrable Securities without registration under the Securities Act within the limitation of the exemptions provided by
(i) Rule 144 under the Securities Act, as such rule may be amended from time to time, or Regulation S under the Securities Act or (ii) any similar rules or regulations hereafter adopted by the Commission. The Company shall,
upon the request of any Designated Holder of Registrable Securities, deliver to such Designated Holder a written statement as to whether it has complied with such requirements. 
 9.2 Form S-3. The Company covenants that from and after the IPO Effectiveness Date, it shall take such action, including the voluntary
registration of its Common Stock under Section 12 of the Exchange Act, as is necessary to enable the Designated Holders to utilize Form S-3 for the sale of their Registrable Securities, such action to be taken as soon as practicable after the
one-year anniversary of the IPO Effectiveness Date occurs. 
 ARTICLE X 
 MISCELLANEOUS 
 10.1 Recapitalizations, Exchanges, etc. The provisions of
this Agreement shall apply to the full extent set forth herein with respect to (i) the Registrable Securities, (ii) any and all shares of Common Stock of the Company into which the Registrable Securities are converted, exchanged or
substituted in any recapitalization or other capital reorganization by the Company and (iii) any and all equity securities of the Company or any successor or assign of the Company (whether by merger, consolidation, sale of assets or otherwise)
which may be issued in respect of, in conversion of, in exchange for or in substitution of, the Registrable Securities and shall be appropriately adjusted for any stock dividends, splits, reverse splits, combinations, recapitalizations and the like
occurring after the date hereof. The Company shall cause any successor or assign (whether by merger, consolidation, sale of assets or otherwise) to enter into a new 
  

 20 

 
registration rights agreement with the Designated Holders on terms substantially the same as this Agreement as a condition of any such transaction.

 10.2 No Inconsistent Agreements. The Company represents and warrants that it has not granted to any Person the right to request or
require the Company to register any securities issued by the Company, other than the rights granted to the Designated Holders herein. The Company shall not enter into any agreement with respect to its securities that is inconsistent with the rights
granted to the Designated Holders in this Agreement or grant any additional registration rights to any Person or with respect to any securities which are not Registrable Securities which are prior in right to or inconsistent with the rights granted
in this Agreement without the written consent of holders of at least a majority of the Registrable Securities. 
 10.3 Remedies. The
Designated Holders, in addition to being entitled to exercise all rights granted by law, including recovery of damages, shall be entitled to specific performance of their rights under this Agreement. The Company agrees that monetary damages would
not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Agreement and hereby agrees to waive in any action for specific performance the defense that a remedy at law would be adequate. 
 10.4 Notices. All notices, demands and other communications provided for or permitted hereunder shall be made in writing and shall be made by
registered or certified first-class mail, return receipt requested, telecopier, courier service or personal delivery: 
 (a) if to the
Company: 
 MAP Pharmaceuticals, Inc. 
 2400 Bayshore Parkway, 2nd Floor 
 Mountain View, CA 94043 
 Telecopy: 650-386-3101 
 Attention: Timothy
S. Nelson 
 with a copy to: 
 Latham & Watkins LLP 
 140 Scott Drive 
 Menlo Park, California 94025 
 Telecopy: 650-463-2600 
 Attention: Patrick A. Pohlen 
 (b) if to any
Investor Stockholder, to the addresses appearing below such Investor Stockholder’s name on Schedule 1. 
 (c) if to any Founding
Stockholder, to the addresses appearing below such Founding Stockholder’s name on the signature pages hereto. 
 (d) if to any other
Designated Holder, at its address as it appears on the record books of the Company. 
  

 21 

 All such notices, demands and other communications shall be deemed to have been duly given: when
delivered by hand, if personally delivered; when delivered by courier, if delivered by commercial courier service; five (5) Business Days after being deposited in the mail, postage prepaid, if mailed; and when receipt is mechanically
acknowledged, if telecopied. Any party may by notice given in accordance with this Section 10.4 designate another address or Person for receipt of notices hereunder. 
 10.5 Successors and Assigns; Third-Party Beneficiaries. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of the parties hereto as hereinafter provided.
The Demand Registration rights and the S-3 Registration rights and related rights of the Investor Stockholders contained in Articles III and V hereof and the rights and obligations of the Investor Stockholders, contained in Article VIII hereof, and
the incidental or “piggy-back” registration rights of the Designated Holders contained in Section 3.2 and Articles IV and V hereof and the other rights of each of the Designated Holders with respect thereto may be, with respect
to any Registrable Security, assigned to a transferee or assignee in connection with any transfer or assignment of Registrable Securities by a Designated Holder of not less than 500,000 shares of Registrable Securities (or all shares of a Designated
Holder’s Registrable Securities if less than 500,000) or to an Affiliate of such Designated Holder (in which case there shall be no restrictions as to minimum shareholdings), as applicable, but only if such Registrable Security is transferred
in compliance with the Restated Stockholders Agreement and such Person agrees in writing to be bound by this Agreement. All of the obligations of the Company hereunder shall survive any such transfer. Except as provided in Article VIII, no Person
other than the parties hereto and their successors and permitted assigns is intended to be a beneficiary of this Agreement. 
 10.6
Amendments and Waivers. Except as otherwise provided herein, the provisions of this Agreement may not be amended, modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given unless consented to
in writing by (i) the Company, (ii) Investor Stockholders holding Registrable Securities representing at least a majority of the aggregate number of Registrable Securities owned by all of the Investor Stockholders and (iii) with
respect to amendments or waivers materially adversely affecting the Founding Stockholders in a manner different than the manner in which the Investor Stockholders are affected, by Founding Stockholders holding Registrable Securities representing at
least a majority of the aggregate number of Registrable Securities owned by all of the Founding Stockholders; provided, however, that the consent of an Investor Stockholder shall be required for any amendment, supplement, modification or
waiver of any term of this Agreement that materially adversely affects such Investor Stockholder in a manner different than the manner in which the other Investor Stockholders are affected. Any such written consent shall be binding upon the Company
and all of the Designated Holders. 
 10.7 Counterparts. This Agreement may be executed in any number of counterparts and by the
parties hereto in separate counterparts, each of which when so 
  

 22 

 
executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. 
 10.8 Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof.

 10.9 GOVERNING LAW; CONSENT TO JURISDICTION. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE
LAWS OF THE STATE OF CALIFORNIA, WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAW THEREOF. EACH OF THE COMPANY, THE INVESTOR STOCKHOLDERS AND THE FOUNDING STOCKHOLDERS HEREBY IRREVOCABLY CONSENTS TO THE EXCLUSIVE JURISDICTION AND VENUE OF THE
STATE OR FEDERAL COURTS LOCATED IN THE STATE OF CALIFORNIA. ANY AND ALL SERVICE OF PROCESS SHALL BE EFFECTIVE AGAINST ANY PARTY OR STOCKHOLDER IF GIVEN PERSONALLY OR BY REGISTERED OR CERTIFIED MAIL, RETURN RECEIPT REQUESTED, OR BY ANY OTHER MEANS OF
MAIL THAT REQUIRES A SIGNED RECEIPT, POSTAGE PREPAID TO SUCH PARTY AS FOLLOWS: (A) AT THE RESPECTIVE ADDRESSES LISTED IN SECTION 10.4 OR (B) AT THE ADDRESS APPEARING BELOW EACH STOCKHOLDER’S NAME ON THE SIGNATURE PAGES HERETO IF
SERVICE OF PROCESS SHALL BE MADE ON A STOCKHOLDER. EACH OF THE PARTIES AND THE STOCKHOLDERS WAIVES ANY RIGHT IT OR HE MAY HAVE TO JURY TRIAL. 
 10.10 Severability. If any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable in any respect for any reason, the validity, legality and
enforceability of any such provision in every other respect and of the remaining provisions hereof shall not be in any way impaired, unless the provisions held invalid, illegal or unenforceable shall substantially impair the benefits of the
remaining provisions hereof. 
 10.11 Rules of Construction. Unless the context otherwise requires, references to sections or
subsections refer to sections or subsections of this Agreement. 
 10.12 Entire Agreement. This Agreement is intended by the parties
as a final expression of their agreement and intended to be a complete and exclusive statement of the agreement and understanding of the parties hereto with respect to the subject matter contained herein. There are no restrictions, promises,
representations, warranties or undertakings with respect to the subject matter contained herein, other than those set forth or referred to herein. This Agreement supersedes all prior agreements and understandings among the parties with respect to
such subject matter. 
 10.13 Further Assurances. Each of the parties shall, and shall cause their respective Affiliates to, execute
such documents and perform such further acts as may be 
  

 23 

 
reasonably required or desirable to carry out or to perform the provisions of this Agreement. 
 10.14 Other Agreements. Nothing contained in this Agreement shall be deemed to be a waiver of, or release from, any obligations any party hereto
may have under, or any restrictions on the transfer of Registrable Securities or other securities of the Company imposed by, any other agreement including, but not limited to, the Series A Purchase Agreement, the Series B Stock Purchase
Agreement, the Series C Stock Purchase Agreement, the Series D Stock Purchase Agreement or the Restated Stockholders Agreement. 
 10.15 Additional Parties. Persons who become “Purchasers” of the Company’s Series D Preferred Stock after the effective date of this Agreement pursuant to and in accordance with the Series D Stock Purchase Agreement
and who execute signature pages to this Agreement shall become parties hereto, and no consent or waiver of any party hereto, other than the Company, shall be required to add such additional party. Upon the accession of such parties to this
Agreement, the Company shall amend Schedule 1 hereto and shall provide such amended Schedule 1 to all other parties hereto. 
 10.16
Termination of the Current Rights Agreement. Upon execution and delivery of this Agreement by the Company and Investor Stockholders holding Registrable Securities (as defined in the Current Rights Agreement) representing at least a majority
of the aggregate number of Registrable Securities (as so defined) owned by all of the Investor Stockholders, the Current Rights Agreement shall terminate. 
 [Signature Pages Follow] 
  

 24 

 IN WITNESS WHEREOF, the undersigned have executed, or have caused to be executed, this Third Amended and
Restated Registration Rights Agreement on the date first written above. 
  

			
	MAP PHARMACEUTICALS, INC.
		
	 By:
	 	 /s/ Timothy S. Nelson

		 	 
	 Name: Timothy S. Nelson

	 Title: President and Chief Executive Officer

 [Signature Page to Third Amended and Restated Registration Rights Agreement]

  

 IN WITNESS WHEREOF, the undersigned have executed, or have caused to be executed, this Third Amended and
Restated Registration Rights Agreement on the date first written above. 
  

			
	PERSEUS-SOROS BIOPHARMACEUTICAL FUND, LP
		
	 By:
	 	 /s/ Jay A. Schoenfarber

		 	 
	 Name: Jay A. Schoenfarber

	 Title: Attorney-in-Fact

 [Signature Page to Third Amended and Restated Registration Rights Agreement]

  

 IN WITNESS WHEREOF, the undersigned have executed, or have caused to be executed, this Third Amended and
Restated Registration Rights Agreement on the date first written above. 
  

			
	 Bay City Capital Management IV, LLC

	 General Partner of:

	
	 BAY CITY CAPITAL FUND IV, L.P.

	
	 By: Bay City Capital LLC, its Manager

		
	 By:
	 	 /s/ Carl Goldfischer

		 	 
	 Name: Carl Goldfischer

	 Title: Manager and Managing Director

	
	 Bay City Capital Management IV, LLC

	 General Partner of:

	
	BAY CITY CAPITAL FUND IV CO-INVESTMENT FUND, L.P.
	
	 By: Bay City Capital LLC, its Manager

		
	 By:
	 	 /s/ Carl Goldfischer

		 	 
	 Name: Carl Goldfischer

	 Title: Manager and Managing Director

 [Signature Page to Third Amended and Restated Registration Rights Agreement]

  

 IN WITNESS WHEREOF, the undersigned have executed, or have caused to be executed, this Third Amended and
Restated Registration Rights Agreement on the date first written above. 
  

					
	 PEQUOT PRIVATE EQUITY FUND III, L.P.

		
	 By:
	 	Pequot Capital Management, Inc.,
		 	as Investment Manager
		
	 By:
	 	/s/ Carlos Rodrigues
		 	 
	 Name:
	 	Carlos Rodrigues
	 Title:
	 	Chief Financial Officer
			
	 Notice to:
	 		 	Aryeh Davis
		 		 	Carlos Rodrigues
		 		 	c/o Pequot Capital Management, Inc.
		 		 	500 Nyala Farm Road
		 		 	Westport, CT 06880
	
	PEQUOT OFFSHORE PRIVATE EQUITY PARTNERS III, L.P.
		
	 By:
	 	Pequot Capital Management, Inc.,
		 	as Investment Manager
		
	 By:
	 	/s/ Carlos Rodrigues
		 	 
	 Name:
	 	Carlos Rodrigues
	 Title:
	 	Chief Financial Officer
			
	 Notice to:
	 		 	Aryeh Davis
		 		 	Carlos Rodrigues
		 		 	c/o Pequot Capital Management, Inc.
		 		 	500 Nyala Farm Road
		 		 	Westport, CT 06880

 [Signature Page to Third Amended and Restated Registration Rights Agreement]

  

 IN WITNESS WHEREOF, the undersigned have executed, or have caused to be executed, this Third Amended and
Restated Registration Rights Agreement on the date first written above. 
  

			
	SKYLINE VENTURE PARTNERS III, L.P.
	
	 By: Skyline Venture Management III, LLC

	 Its: General Partner

		
	 By:
	 	 /s/ John G. Freund

		 	 
	 Name: John G. Freund

	 Title: Managing Director

	
	SKYLINE VENTURE PARTNERS QUALIFIED PURCHASER FUND III, L.P.
	
	 By: Skyline Venture Management III, LLC

	 Its: General Partner

		
	 By:
	 	 /s/ John G. Freund

		 	 
	 Name: John G. Freund

	 Title: Managing Director

 [Signature Page to Third Amended and Restated Registration Rights Agreement]

  

 IN WITNESS WHEREOF, the undersigned have executed, or have caused to be executed, this Third Amended and
Restated Registration Rights Agreement on the date first written above. 
  

			
	SKYLINE EXPANSION FUND, L.P.
	
	 By: Skyline Expansion Fund Management, LLC

	 Its: General Partner

	 By: Skyline Venture Management III, LLC

	 Its: Managing Member

		
	 By:
	 	 /s/ John G. Freund

		 	 
	 Name: John G. Freund

	 Title: Managing Director

 [Signature Page to Third Amended and Restated Registration Rights Agreement]

  

 IN WITNESS WHEREOF, the undersigned have executed, or have caused to be executed, this Third Amended and
Restated Registration Rights Agreement on the date first written above. 
  

			
	 BROOKSIDE CAPITAL PARTNERS FUND, L.P.

	
	By: Brookside Capital Investors, L.P., its general partner
	By: Brookside Capital Management, LLC, its general partner
		
	 By:
	 	 /s/ Matthew McPherron

		 	 
	 Name: Matthew McPherron

	 Title: Managing Director

 [Signature Page to Third Amended and Restated Registration Rights Agreement]

  

 IN WITNESS WHEREOF, the undersigned have executed, or have caused to be executed, this Third Amended and
Restated Registration Rights Agreement on the date first written above. 
  

			
	 ALEXANDRIA EQUITIES, LLC,

	 a Delaware limited liability company

	
	 By:   ALEXANDRIA REAL ESTATE EQUITIES, INC., a Maryland corporation, managing member

		
	 By:
	 	/s/ Etsuko Mason
		 	 
	 Name:
	 	Etsuko Mason
	Title:	 	Vice President, Treasurer & Assistant Secretary

 [Signature Page to Third Amended and Restated Registration Rights Agreement]

  

 IN WITNESS WHEREOF, the undersigned have executed, or have caused to be executed, this Third Amended and
Restated Registration Rights Agreement on the date first written above. 
  

			
	D. E. SHAW MENISCUS PORTFOLIOS, L.L.C.
	
	 By: D. E. Shaw & Co., L.L.C., as managing member

		
	By:	 	/s/ Anne Dinning
		 	 
	Name:	 	Anne Dinning
	Title:	 	Managing Director

 [Signature Page to Third Amended and Restated Registration Rights Agreement]

  

 IN WITNESS WHEREOF, the undersigned have executed, or have caused to be executed, this Third Amended and
Restated Registration Rights Agreement on the date first written above. 
  

			
	 OXFORD FINANCE CORPORATION,

	 a Delaware corporation

		
	By:	 	/s/ Michael J. Altenburger
		 	 
	Name:	 	Michael J. Altenburger
	Title:	 	Chief Financial Officer

 [Signature Page to Third Amended and Restated Registration Rights Agreement]

  

 IN WITNESS WHEREOF, the undersigned have executed, or have caused to be executed, this Third Amended and
Restated Registration Rights Agreement on the date first written above. 
  

	
	 /s/ Thomas A. Armer

	 
	 Name: Thomas A. Armer

	 State of Residence:

	 Address:

	
	 /s/ Thomas K. Garver

	 
	 Name: Thomas K. Garver

	 State of Residence:

	 Address:

	
	 /s/ Michael S. McCord

	 
	 Name: Michael S. McCord

	 State of Residence:

	 Address:

	
	 /s/ Marc J. Minkoff

	 
	 Name: Marc J. Minkoff

	 State of Residence:

	 Address:

	
	 /s/ Michael G. Boulegeris

	 
	 Name: Michael G. Boulegeris

	 State of Residence:

	 Address:

	
	 THE MICHAEL S. MCCORD GST TRUST

	
	 By: /s/ Michael S. McCord

	 
	 Name: Michael S. McCord

	 Title: Trustee

 [Signature Page to Third Amended and Restated Registration Rights Agreement]

  

 IN WITNESS WHEREOF, the undersigned have executed, or have caused to be executed, this Third Amended and
Restated Registration Rights Agreement on the date first written above. 
  

			
	 VP COMPANY INVESTMENTS 2004, LLC,

	 a Delaware limited liability company

		
	 By:
	 	 /s/ Alan Mendelson

		 	 
	 Name: Alan Mendelson

	 Title: Managing Member

	
	 THE MENDELSON FAMILY TRUST

		
	 By:
	 	 /s/ Alan Mendelson

		 	 
	 Name: Alan Mendelson

	 Title: Trustee

	
	 /s/ Patrick A. Pohlen

	 
	 Name: Patrick A. Pohlen

	 State of Residence: 

	 Address: 

	

 [Signature Page to Third Amended and Restated Registration Rights Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}]]